Loading clinical trials...
Loading clinical trials...
Prospective, Multi-centre Clinical Investigation Evaluating the Outcomes of Patients Treated by Redo Transcatheter Aortic Valve Implantation for Bioprosthetic Valve Failure of a Transcatheter Aortic Valve
Conditions
Interventions
Any commercially available Edwards or Medtronic transcatheter aortic valve with the TAV-in-TAV (Redo TAVI) indication
Surgical explantation and aortic valve replacement
+1 more
Locations
61
Denmark
Aalborg Universitethospital
Aalborg, Denmark
Århus Universitetshospital
Aarhus, Denmark
Rigshospitalet
Copenhagen, Denmark
HUS Helsinki University Hospital
Helsinki, Finland
Turku University Hospital
Turku, Finland
Clinical Saint Augustin - Elsan
Bordeaux, France
Start Date
December 12, 2024
Primary Completion Date
June 1, 2027
Completion Date
March 1, 2033
Last Updated
April 6, 2026
NCT07001800
NCT07477002
NCT06535659
NCT05172973
NCT03549559
NCT05672836
Lead Sponsor
The Leeds Teaching Hospitals NHS Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions